Medicare to Cover PrEP and Associated Services Under Part B Only
CMS announced that it expects to release a final National Coverage Determination (NCD) late next month that will move the PrEP coverage benefit from Medicare Part D to Medicare Part…
Emily Blaiklock and Bill Keeton featured in American Journal of Managed Care
On June 21, 2024, the American Journal of Managed Care ran an article titled “Protecting the 340B Program Vital for Providing the Best Care to Patients With HIV” that detailed…
RWC in the news: Emily Blaiklock and Bill Keeton featured in the Times West Virginian
On June 11, 2024, the Times West Virginian ran a story titled “Federal drug pricing program 340B important for rural health care providers in W.Va.” which articulates and underscores the…
Two Covered Entity Hospitals Sue HRSA Over Johnson & Johnson Request for Audit
On July 24, 2024, two hospital-covered entities sued the Health Resources and Services Administration (“HRSA”), arguing that HRSA’s approval of J&J’s 340B audit request against them was unlawful and premature. The…
Alkermes and Viatris Impose 340B Program Contract Pharmacy Restrictions
Alkermes and Viatris have become the 36th and 37th manufacturers, respectively, to impose restrictions on contract pharmacy arrangements. These restrictions are effective July 22 and August 1, respectively, but please…
340B ACCESS Act Harms Persons Living with HIV/AIDS
RWC-340B Fact Sheet – Oppose 340B ACCESS Act
RWC-340B Signs Onto Joint Letter Providing Draft Guidance on the Inflation Reduction Act (IRA)
RWC-340B was asked to sign onto the attached letter to CMS commenting on its May 3, 2024 Draft Guidance implementing aspects of the Inflation Reduction Act (IRA). 340B Health drafted the…
RWC-340B Comparison of 340B Principles and Legislation
RWC-340B Comparison of 340B Principles and Legislation Chart. Comparison of 340B Principles and Legislation Chart.pdf
RWC-340B Urges Congress to Soundly Reject House Republicans “340B Access Act”
RWC-340B releases press statement urging Congress to soundly reject House Republicans “340B Access Act”. “Disguised as a genuine reform effort, the bill would diminish the program’s benefits to favor drug…
Decision Against HRSA by D.C. Circuit Court of Appeals
Today, the D.C. Circuit Court of Appeals issued its decision regarding HRSA’s enforcement authority to prevent contract pharmacy restrictions imposed by Novartis and United Therapeutics. Novartis limits hospital covered entities…